Esperion Therapeutics, Inc. (ESPR)
3.79
-0.12
(-3.07%)
USD |
NASDAQ |
Dec 09, 16:00
3.82
+0.03
(+0.79%)
Pre-Market: 08:41
Esperion Therapeutics Free Cash Flow: -124.49M for June 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 20.46B |
| Ovid Therapeutics, Inc. | -37.93M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -0.1211 |
| Free Cash Flow to Equity (Quarterly) | -28.10M |
| Free Cash Flow to Firm (Quarterly) | -3.436M |
| Free Cash Flow Yield | -16.63% |